A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country
- Resource Type
- Source
- Vaccine. 41:1398-1407
- Subject
Infectious Diseases General Veterinary General Immunology and Microbiology Public Health, Environmental and Occupational Health Molecular Medicine - Language
- ISSN
- 0264-410X